58433-11-7

Usage

InChI:InChI=1/C17H11ClN2O2S/c18-11-7-5-10(6-8-11)16-14(9-15(21)22)23-17-19-12-3-1-2-4-13(12)20(16)17/h1-8H,9H2,(H,21,22)

Upstream product

• 16458-73-4 2-methylbenzo[4,5]imidazo[2,1-b]thiazole 
• 650-51-1 sodium trichloroacetate 
• 98041-44-2 2-iodophenyl isothiocyanate 
• 39481-06-6 [3-(4-chloro-phenyl)-3-hydroxy-2,3-dihydro-benzo[4,5]imidazo[2,1-b]thiazol-2-yl]-acetic acid; hydrobromide 
• 35158-39-5 3-bromo-3-(4-chlorobenzoyl)propionic acid 
• 39225-24-6 ethyl 3-(benzimidazol-2-ylthio)-3-(p-chlorobenzoyl)propionate hydrobromide 
• 39225-26-8 3-(p-Chlorophenyl)-2,3-dihydro-3-hydroxy-thiazolo[3,2-a]-benzimidazole-2-acetic acid 
• 39225-25-7 [3-(4-chloro-phenyl)-3-hydroxy-2,3-dihydro-benzo[4,5]imidazo[2,1-b]thiazol-2-yl]-acetic acid ethyl ester 
• 134469-07-1 Benzimidazol-2-thiol 

Relevant academic research and scientific papers

Synthesis method of thiazolo [3,2-a] benzimidazole compound and its application

The present invention provides a synthesis method of thiazolo [3,2-a] benzimidazole compounds, the synthesis method of alkyne does not require pre-functionalization, the synthesis steps are simple; the reaction conditions are mild, can be reacted at room

Process for preparing thiazolobenzimidazoles and intermediates used therein

The invention concerns a process for preparing a thiazolo[3,2-a]benzimidazole of formula I STR1 in which formula n is 1 or 2, and R1 is hydrogen, lower alkyl, lower alkoxy, trifluoromethyl or halo, or a salt thereof which comprises dehydrating

Vaccine adjuvants

There are disclosed mammalian vaccine compositions comprising an inactivated whole or subunit vaccine or toxoid and an adjuvant having the formula STR1 wherein R is hydrogen or lower alkyl, R1 is hydrogen, lower alkyl, lower alkoxy, trifluorome

Thiazolo[3,2-a]benzimidazoles, imidazo [2,1-b]thiazoles, and related compounds as antineoplastic agents, and enhancers of the immune response

The use of 3-aryl-thiazolo[3,2-a]benzimidazoles, 3-aryl-imidazo[2,1-b]thiazoles, and related compounds as antineoplastic agents, and/or as enhancers of the immune response is disclosed.

Syntheses of heterocyclic fused thiazole acetic acids. 2

A number of tricyclic and bicyclic fused thiazole 2 acetic acid derivatives were prepared and the chemistry and biological properties of these compounds are discussed. Many of the esters exhibited antitubercular activity. The bicyclic thiazole 2 acetic ac